Guillain–Barré syndrome (GBS) is an acute polyradiculoneuropathy. Symptoms may vary
greatly in presentation and severity. Besides weakness and sensory disturbances, patients …

Acute motor axonal neuropathy (AMAN) is a pure motor axonal subtype of Guillain-Barré
syndrome (GBS) that was identified in the late 1990s. In Asia and Central and South …

Objectives: To determine which antecedent infections are specifically associated with the
Guillain-Barré syndrome (GBS). Background: Infections with many agents have been …

Background: Guillain-Barré syndrome (GBS) has a highly diverse clinical course and
outcome, yet patients are treated with a standard therapy. Patients with poor prognosis may …

This review charts the progress of anti‐glycolipid antibodies in neuropathy, from their
original discovery 20 years ago in immunoglobulin M paraproteinaemic neuropathy through …

Objective Respiratory insufficiency is a frequent and serious complication of the Guillain‐
Barré syndrome (GBS). We aimed to develop a simple but accurate model to predict the …

Molecular mimicry. The initial expansion of naive autoreactive T cells requires activation of
the TCR by MHC-bound peptides or CD1-bound lipids/glycolipids. The molecular mimicry …

Guillain-Barré syndrome (GBS) is viewed as a reactive, self-limited, autoimmune disease
triggered by a preceding bacterial or viral infection. Campylobacter jejuni, a major cause of …

Background and Objectives Infections play a key role in the development of Guillain-Barré
syndrome (GBS) and have been associated with specific clinical features and disease …

Background Despite available treatment with intravenous immunoglobulin (IVIg), morbidity
and mortality are considerable in patients with Guillain-Barré syndrome (GBS). Our aim was …